Results 91 to 100 of about 7,666 (128)

Acellular Pertussis Vaccine Effectiveness Over Time. [PDF]

Pediatrics, 2019
Zerbo O, Bartlett J, Goddard K, Fireman B, Lewis E, Klein NP.   +5 more
europepmc   +1 more source

Maternal Vaccination in Argentina: Tetanus, Diphtheria, and Acellular Pertussis Vaccine Effectiveness During Pregnancy in Preventing Pertussis in Infants <2 Months of Age. [PDF]

Clin Infect Dis, 2020
Romanin V, Acosta AM, Juarez MDV, Briere E, Sanchez SM, Cordoba BL, Sevilla ME, Lucion MF, Urrutia A, Sagradini S, Skoff TH, Vizzotti C.   +11 more
europepmc   +1 more source

Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study. [PDF]

Hum Vaccin Immunother, 2021
Asatryan A, Meyer N, Scherbakov M, Romanenko V, Osipova I, Galustyan A, Shamsheva O, Latysheva T, Myasnikova T, Baudson N, Dodet M, Xavier S, Harrington L, Kuznetsova A, Campora L, Van den Steen P.   +15 more
europepmc   +1 more source

A model based evaluation of the 1996-7 pertussis epidemic in the Netherlands

, 2001
van Boven, M., Melker, H.E., de, Boven, M., van, de Melker, H.E., Schellekens, J.F.P., Kretzschmar, M.   +5 more
core  

The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies. [PDF]

Front Immunol, 2019
Abu-Raya B, Giles ML, Kollmann TR, Sadarangani M.   +3 more
europepmc   +1 more source

Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda.

Lancet Glob Health
Nakabembe E, Greenland M, Amaral K, Abu-Raya B, Amone A, Andrews N, Cantrell L, Lesne E, Gorringe A, Halkerston R, Mcstraw N, Dixon L, Hunter OF, Heath PT, Imede E, Kyohere M, Musoke P, Nakimuli A, Sekikubo M, Taylor S, Tusubira V, Sadarangani M, Le Doare K.   +22 more
europepmc   +1 more source

Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women. [PDF]

Vaccine, 2018
Fortner KB, Swamy GK, Broder KR, Jimenez-Truque N, Zhu Y, Moro PL, Liang J, Walter EB, Heine RP, Moody MA, Yoder S, Edwards KM.   +11 more
europepmc   +1 more source

Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial.

JAMA Pediatr, 2018
Wood N, Nolan T, Marshall H, Richmond P, Gibbs E, Perrett K, McIntyre P.   +6 more
europepmc   +1 more source

<i>Bordetella pertussis</i> Infection: From Immune Pathogenesis to Next-Generation Vaccines. [PDF]

Vaccines (Basel)
Georgakopoulou VE, Pitiriga VC.
europepmc   +1 more source

Preclinical study on an adsorbed acellular diphtheria- tetanus-pertussis (reduced-dose) combined vaccine: evaluation of reproductive safety and immunogenicity. [PDF]

Front Immunol
Chu H, Kong W, Gu Q, Ma Y, Cai L, Li J, Wang X, Ji Q, Wen J, Gao N, Ji G, Hu W, Zhao T, Ping L, Fu Y, Li Y, Gong T, Jin Y, Yang Y, Fu Y, Qin X, Zheng H, Yang J, Liang J.   +23 more
europepmc   +1 more source